A mission-oriented industry consortium formed of biotech and pharma members to build software which makes science faster, improves quality, decreases cost and enables continuous innovation at scale.
One cloud-native platform empowers labs of all functions and sizes to seamlessly manage data production and data consumption for all scientific workflows, accelerating discovery through intuitive user experience, robust data security, comprehensive compliance, laboratory orchestration, and dynamic interoperability between systems.
Usage-based licensing and the not-for-profit product commercial model enable cost saving for consumers while maintaining a best-in-class product to be adopted ubiquitously across industry.
The Digital Science Development Consortium solves scientific industry digital problems through member investment and collaboration to build and transfer software products into a sustainable commercial provider ecosystem to solve pre- and non-competitive industry needs where commercial solutions have failed.
The pace of scientific innovation has accelerated dramatically in the past 20 years yet our productivity in industry for discovery and delivery of new medicines has remained largely unchanged. Among several macro-challenges, the digital tools scientists have to research and manufacture new medicines has failed to adapt. Today, laboratories work around their software tools at the expense of productivity and scientific innovation. This must change and it must change using a completely different paradigm which revolutionizes the entire industry from startups to global pharmaceutical companies.
read moreJohn Harman, frustrated by decades of inadequate R&D lab informatics solutions, initiated a new project in December 2023. independent of any organization, aiming to address life sciences R&D challenges he "formed" (unofficial) the Digital Science Development Consortium, a model for industry to fund a not-for-profit software product. which improves the effectiveness of every human and machine working in laboratories. Transparent progress updates and solicitation for membership and non-conventional funding efforts are ongoing, with key business and architectural designs published for industry review.
read more